Statement by CMO, CHRISTUS Spohn Health System, Update on Heparin Matter

FOR IMMEDIATE RELEASE 7/8/2008 12:00:00 AM PACIFIC Updated: 7/10/2008 9:43:18 AM PACIFIC

Statement by Dr. Richard Davis, Chief Medical Officer, CHRISTUS Spohn Health System Update on Heparin Matter, July 9, 2008, 11:15 a.m.

Corpus Christi, Texas (July 9, 2008) – The attending neonatologist states that at this point, there are no identifiable adverse affects directly caused by Heparin. Thirteen of the infants remain in our NICU for reasons unrelated to Heparin. Twelve of the infants are in stable condition and one remains in critical and unstable condition. We are closely monitoring their progress.

Our highly experienced and dedicated neonatal staff and physicians have taken extraordinary measures to deliver the best care possible and remain in close contact with the families.

All babies who come to our NICU are seriously ill. Our NICU is a Level 3 facility for critically ill infants who are born prematurely, typically between 24 and 36 weeks. Many of these infants have low birth weights with multiple medical problems.

We continue to keep the babies and their families in our thoughts and prayers.

CHRISTUS Spohn Health System is the region’s largest charity care provider and not-for-profit health care system consisting of six hospital campuses - CHRISTUS Spohn Hospital Corpus Christi (Shoreline, Memorial and South), CHRISTUS Spohn Hospital Alice, CHRISTUS Spohn Hospital Beeville and CHRISTUS Spohn Hospital Kleberg (Kingsville). The health system is consistently ranked as a leading health system in the area and has received national recognition for several pioneering programs, including cardiac care, clinical excellence and oncology. For more than 100 years, CHRISTUS Spohn has been distinguished by its high caliber staff and affiliated physicians, its comprehensive and innovative services, and its long history of responding to the needs of the community it serves. For additional information, visit our website at